We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Crism Therapeutics Corporation | LSE:CRTX | London | Ordinary Share | VGG042401262 | ORD NPV |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.75 | 33,730 | 08:00:21 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 10.50 | 13.00 | 11.75 | 9.75 | 11.75 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Mineral Royalty Traders | USD 512k | USD -9.65M | USD -0.2331 | -0.50 | 4.86M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:48:45 | O | 1,412 | 10.65 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/9/2024 | 06:00 | UK RNS | CRISM Therapeutics Corporation Interim Results |
| 09/9/2024 | 06:00 | UK RNS | CRISM Therapeutics Corporation Notice of Interim Results & IMC Presentation |
| 03/9/2024 | 06:00 | UK RNS | CRISM Therapeutics Corporation Delivery Method Validated in Peer Reviewed.. |
| 02/9/2024 | 06:00 | UK RNS | CRISM Therapeutics Corporation Innovation Passport Award |
| 30/7/2024 | 06:00 | UK RNS | Crism Therapeutics Corporation CRISM Signs Service Agreement Contract |
| 03/7/2024 | 18:03 | ALNC |  IN BRIEF: Crism flags contract talks, reacts to share price surge |
| 03/7/2024 | 15:18 | UK RNS | Crism Therapeutics Corporation Response to Movement in Share Price |
| 03/6/2024 | 14:25 | UK RNS | Crism Therapeutics Corporation Director Dealing |
| 31/5/2024 | 20:58 | ALNC | IN BRIEF: Crism has first day of trade on AIM after name change, buy |
| 31/5/2024 | 06:00 | UK RNS | Crism Therapeutics Corporation Admission to Trading and First Day of.. |
Crism Therapeutics (CRTX) Share Charts1 Year Crism Therapeutics Chart |
|
1 Month Crism Therapeutics Chart |
Intraday Crism Therapeutics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 08/12/2024 | 20:51 | Crism Therapeutics new beginning | 112 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 09:48:46 | 10.65 | 1,412 | 150.38 | O |
| 09:15:37 | 10.65 | 20,000 | 2,130.00 | O |
| 09:13:37 | 10.73 | 2,769 | 297.11 | O |
| 08:26:13 | 11.99 | 5,588 | 670.00 | O |
| 08:01:57 | 11.99 | 3,961 | 474.92 | O |
| Top Posts |
|---|
Posted at 12/12/2024 08:20 by Crism Therapeutics Daily Update Crism Therapeutics Corporation is listed in the Mineral Royalty Traders sector of the London Stock Exchange with ticker CRTX. The last closing price for Crism Therapeutics was 11.75p.Crism Therapeutics currently has 41,383,439 shares in issue. The market capitalisation of Crism Therapeutics is £4,862,554. Crism Therapeutics has a price to earnings ratio (PE ratio) of -0.50. This morning CRTX shares opened at 11.75p |
Posted at 08/12/2024 20:51 by greenvulcan Should find out this week what all the flurry of buys were about on Friday afternoonThis share can really move through the gears and if news of their business being successful in medical trials or new deals for their tech then could be a good moment to pile in |
Posted at 16/7/2024 10:34 by tidy 2 CRISM Therapeutics Corporation ("CRISM" or the "Company") notes the increase in the Company's share price today and confirms that it is not aware of any specific reason for the increase. The Company's share price has fallen since admission to AIM (Admission) on 31 May 2024, and today's price reversal reflects the Board's underlying view of the value of the business. The Company continues to work on its stated strategy of submitting a Clinical Trial Application in the second half of 2024 for its lead product, ChemoSeed. The Company is also at contract stage to provide services with an early stage UK SME who are seeking to utilise CRISM's drug formulation expertise. The value of that contract would be approximately £230k + VAT. A further announcement will be made in due course. |
Posted at 04/7/2024 13:39 by talais Not many share in free floathttps://www.cri |
Posted at 04/7/2024 07:51 by gizmohican This share is bonkers |
Posted at 03/7/2024 13:57 by talais Could be looking at £3 a share |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
